Suppression of Runx2 protein degradation by fibrous engineered matrix

Biomaterials

Volumn 32, Issue 25, 2011, Pages 5826-5836

  Oh, Joung Hwan ^a   Seo, Jihye ^a   Yoon, Won Joon ^a   Cho, Je Yoel ^b   Baek, Jeong Hwa ^a   Ryoo, Hyun Mo ^a   Woo, Kyung Mi ^a  

^a Seoul National University   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Bone tissue engineering; Collagen structure; Fibrous structure; Protein degradation; Runx2; Surface topology

Indexed keywords

BONE TISSUE ENGINEERING; COLLAGEN STRUCTURE; FIBROUS STRUCTURES; PROTEIN DEGRADATION; RUNX2; SURFACE TOPOLOGY;

BONE; COLLAGEN; OSTEOBLASTS; POLYSTYRENES; SYNTHETIC FIBERS; TISSUE; TISSUE CULTURE; TISSUE ENGINEERING; TRANSCRIPTION FACTORS;

DEGRADATION;

COLLAGEN; COLLAGEN FIBER; COLLAGENASE; POLYSTYRENE; TRANSCRIPTION FACTOR RUNX2; UBIQUITIN;

ARTICLE; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TISSUE ENGINEERING;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA PRIMERS; MICE; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

EID: 79957909855     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.04.074     Document Type: Article

References (37)

1. Ma P.X. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 2008, 60:184-198.
2. Lynch M.P., Stein J.L., Stein G.S., Lian J.B. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblast: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res 1995, 216:35-45.
3. Mizuno M., Fujisawa R., Kuboki Y. Type I collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagen-α2β1 integrin interaction. J Cell Physiol 2000, 184:207-213.
4. Li W.J., Laurencin C.T., Caterson E.J., Tuan R.S., Ko F.K. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res 2002, 60:613-621.
5. Wnek G.E., Carr M.E., Simpson D.G., Bowlin G.L. Electrospinning of nanofibre fibrinogen structures. Nano Lett 2003, 3:213-216.
6. Yoshimoto H., Shin Y.M., Terai H., Vacanti J.P. A biodegradable nanofibre scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 2003, 24:2077-2082.
7. Luo Z., Zhao X., Zhang S. Self-Organization of a chiral D-EAK16 designer peptide into a 3D nanofibre scaffold. Macromol Biosci 2008, 8:785-791.
8. Beniash E., Hartgerink J.D., Storrie H., Stendahl J.C., Stupp S.I. Self-assembling peptide amphiphile nanofibre matrices for cell entrapment. Acta Biomater 2005, 1:387-397.
9. Chen V.J., Ma P.X. Nano-fibrous poly(L-lactic acid) scaffolds with interconnected spherical macropores. Biomaterials 2004, 25:2065-2073.
10. Woo K.M., Jun J.H., Chen V.J., Seo J., Baek J.H., Ryoo H.M., et al. Nano-fibrous scaffolding promotes osteoblast differentiation and biomineralization. Biomaterials 2007, 28:335-343.
11. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
12. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
13. Prince M., Banerjee C., Javed A., Green J., Lian J.B., Stein G.S., et al. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem 2001, 80:424-440.
14. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
15. Xiao G., Gopalakrishnan R., Jiang D., Reith E., Benson M.D., Franceschi R.T. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathway are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002, 17:101-110.
16. Tamura Y., Takeuchi Y., Suzawa M., Fukumoto S., Kato M., Miyazono K., et al. Focal adhesion kinase activity is required for bone morphogenetic protein-Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells. J Bone Miner Res 2001, 16:1772-1779.
17. Zhao Z., Zhao M., Xiao G., Franceschi R.T. Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol Ther 2005, 12:247-253.
18. Phillips J.E., Hutmacher D.W., Guldberg R.E., García A.J. Mineralization capacity of Runx2/Cbfa1-genetically engineered fibroblasts is scaffold dependent. Biomaterials 2006, 27:5535-5545.
19. Zhao M., Qiao M., Harris S.E., Oyajobi B.O., Mundy G.R., Chen D. Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J Biol Chem 2004, 279:12854-12859.
20. Yamashita M., Ying S.X., Zhang G.M., Li C., Cheng S.Y., Deng C.X., et al. Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 2005, 121:101-113.
21. Jeon E.J., Lee K.Y., Choi N.S., Lee M.H., Kim H.N., Jin Y.H., et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem 2006, 281:16502-16511.
22. Jun J.H., Yoon W.J., Seo S.B., Woo K.M., Kim G.S., Ryoo H.M., et al. BMP2-activated Erk/MAP kinase stabilises Runx2 by increasing p300 levels and histone acetyltransferase activity. J Biol Chem 2010, 285:36410-36419.
23. Park O.J., Kim H.J., Woo K.M., Baek J.H., Ryoo H.M. FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization. J Biol Chem 2010, 285:3568-3574.
24. Lee M.H., Kim Y.J., Kim H.J., Park H.D., Kang A.R., Kyung H.M., et al. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 2003, 278:34387-34394.
25. Xu L., Anderson A.L., Lu Q., Wang J. Role of fibrillar structure of collagenous carrier in bone sialoprotein-mediated matrix mineralization and osteoblast differentiation. Biomaterials 2007, 28:750-761.
26. Marini J.C., Forlino A., Cabral W.A., Barnes A.M., San Antonio J.D., Milgrom S., et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 2007, 28:209-221.
27. Wallace J.M., Orr B.G., Marini J.C., Holl M.M. Nanoscale morphology of Type I collagen is altered in the Brtl mouse model of Osteogenesis Imperfecta. J Struct Biol 2011, 173:146-152.
28. Karsenty G. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 2008, 9:183-196.
29. Franceschi R.T., Xiao G., Jiang D., Gopalakrishnan R., Yang S., Reith E. Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Connect Tissue Res 2003, 44(Suppl. 1):109-116.
30. Moursi A.M., Globus R.K., Damsky C.H. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci 1997, 110:2187-2196.
31. Knight C.G., Morton L.F., Peachey A.R., Tuckwell D.S., Farndale R.W., Barnes M.J. The collagen-binding A-domains of integrins alpha(1)-beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem 2000, 275:35-40.
32. Messent A.J., Tuckwell D.S., Knäuper V., Humphries M.J., Murphy G., Gavrilovic J. Effects of collagenase-cleavage of type I collagen on alpha2beta1 integrin-mediated cell adhesion. J Cell Sci 1998, 111:1127-1135.
33. Woo K.M., Chen V.J., Ma P.X. Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. J Biomed Mater Res A 2003, 67:531-537.
34. Woo K.M., Chen V.J., Jung H.M., Kim T.I., Shin H.I., Baek J.H., et al. Comparative evaluation of nanofibrous scaffolding for bone regeneration in critical-size calvarial defects. Tissue Eng Part A 2009, 15:2155-2162.
35. Guilak F., Cohen D.M., Estes B.T., Gimble J.M., Liedtke W., Chen C.S. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 2009, 5:17-26.
36. McBeath R., Pirone D.M., Nelson C.M., Bhadriraju K., Chen C.S. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 2004, 6:483-495.
37. Arnold M., Cavalcanti-Adam E.A., Glass R., Blümmel J., Eck W., Kantlehner M., et al. Activation of integrin function by nanopatterned adhesive interfaces. ChemPhysChem 2004, 5:383-388.